Revision surgery after shoulder arthroplasty in The Netherlands, a national registry study
Approval date: June 20th 2025
Starting date: July 1st 2025
FA de Boer, PB de Witte, RGHH Nelissen, MGP Wigchert, MGJ Gademan
Research proposal abstract:
Over the last few years there has been a tremendous increase in the use of shoulder
arthroplasty for various indications, including glenohumeral arthritis, rotator cuff
arthropathy and proximal humerus fracture (and sequelae). It is remarkable, that the
largest increase in shoulder arthroplasties has been for the reversed prosthesis (rTSP),
which is currently the most frequently used technique. However, little is known on the
survival rates of various shoulder arthroplasty techniques. Furthermore, the options for
failed reversed arthroplasty are more limited than for failed anatomical arthroplasty (aTSP).
With this increase in primary arthroplasty, especially for reverse arthroplasty, a rise in
revision shoulder arthroplasty can be expected in the near future. It is therefore important
to evaluate survival rates and risk factors for revision for both anatomic and reverse
prostheses, to guide decision making in shoulder arthroplasty and to manage patient
expectations.
In this retrospective cohort study, using data from 2014 to 2025 from the Dutch
Arthroplasty Registry (LROI), we aim to describe 10 year prosthesis survival and risk
factors for revision in shoulder arthroplasty between anatomical and reverse shoulder
arthroplasty.